Search

Amber D. Steele

Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )

Most Active Art Unit
1658
Art Unit(s)
1654, 1639, 1658, 1676
Total Applications
1302
Issued Applications
628
Pending Applications
166
Abandoned Applications
538

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18056519 [patent_doc_number] => 20220387605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => COMPOSITIONS AND METHODS COMPRISING SELF-ASSEMBLING PEPTIDE-POLYMER NANOFIBERS FOR SUBLINGUAL IMMUNIZATION [patent_app_type] => utility [patent_app_number] => 16/632226 [patent_app_country] => US [patent_app_date] => 2018-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21900 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632226 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/632226
COMPOSITIONS AND METHODS COMPRISING SELF-ASSEMBLING PEPTIDE-POLYMER NANOFIBERS FOR SUBLINGUAL IMMUNIZATION Jul 17, 2018 Pending
Array ( [id] => 13793031 [patent_doc_number] => 20190010054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-10 [patent_title] => SELF ASSEMBLING BETA-BARREL PROTEINS POSITION NANOTUBES [patent_app_type] => utility [patent_app_number] => 16/038084 [patent_app_country] => US [patent_app_date] => 2018-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11734 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16038084 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/038084
Self assembling beta-barrel proteins position nanotubes Jul 16, 2018 Issued
Array ( [id] => 16204935 [patent_doc_number] => 20200237925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-30 [patent_title] => POLYPEPTIDE EYE ABSORPTION ENHANCER AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/618915 [patent_app_country] => US [patent_app_date] => 2018-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6764 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16618915 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/618915
Polypeptide eye absorption enhancer and use thereof Jul 12, 2018 Issued
Array ( [id] => 19121034 [patent_doc_number] => 11965004 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-23 [patent_title] => Molecular guide system peptides and uses thereof [patent_app_type] => utility [patent_app_number] => 16/629799 [patent_app_country] => US [patent_app_date] => 2018-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 31 [patent_no_of_words] => 10645 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16629799 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/629799
Molecular guide system peptides and uses thereof Jul 9, 2018 Issued
Array ( [id] => 16156523 [patent_doc_number] => 20200216494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-09 [patent_title] => A METHOD OF TREATMENT [patent_app_type] => utility [patent_app_number] => 16/624367 [patent_app_country] => US [patent_app_date] => 2018-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20834 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -42 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16624367 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/624367
Method of treatment Jun 28, 2018 Issued
Array ( [id] => 17649675 [patent_doc_number] => 11352389 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-07 [patent_title] => Treatment of haematological malignancies [patent_app_type] => utility [patent_app_number] => 16/627230 [patent_app_country] => US [patent_app_date] => 2018-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 42 [patent_no_of_words] => 31097 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16627230 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/627230
Treatment of haematological malignancies Jun 27, 2018 Issued
Array ( [id] => 15963121 [patent_doc_number] => 20200165312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-28 [patent_title] => COSMETIC COMPOSITION FOR IMPROVING SKIN CONDITIONS COMPRISING FUSION PROTEIN INCLUDING SKIN PENETRATION ENHANCING PEPTIDE [patent_app_type] => utility [patent_app_number] => 16/627116 [patent_app_country] => US [patent_app_date] => 2018-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17595 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16627116 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/627116
COSMETIC COMPOSITION FOR IMPROVING SKIN CONDITIONS COMPRISING FUSION PROTEIN INCLUDING SKIN PENETRATION ENHANCING PEPTIDE Jun 27, 2018 Abandoned
Array ( [id] => 14913613 [patent_doc_number] => 10428113 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-01 [patent_title] => Compositions for expanding regulatory T cells (Treg), and treating autoimmune and inflammatory diseases and conditions [patent_app_type] => utility [patent_app_number] => 16/022306 [patent_app_country] => US [patent_app_date] => 2018-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 25 [patent_no_of_words] => 20350 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16022306 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/022306
Compositions for expanding regulatory T cells (Treg), and treating autoimmune and inflammatory diseases and conditions Jun 27, 2018 Issued
Array ( [id] => 13476629 [patent_doc_number] => 20180289857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-11 [patent_title] => COMPOSITE COLLAGEN HYDROGEL MATERIAL, AN IMPLANTABLE OPHTHALMIC DEVICE COMPRISING SUCH MATERIAL AND METHODS OF PRODUCING THE COMPOSITE COLLAGEN HYDROGEL MATERIAL AND THE IMPLANTABLE OPHTHALMIC DEVICE [patent_app_type] => utility [patent_app_number] => 16/003424 [patent_app_country] => US [patent_app_date] => 2018-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8518 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16003424 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/003424
Composite collagen hydrogel material, an implantable opthalmic device comprising such material and methods of producing the composite collagen hydrogel material and the implantable ophthalmic device Jun 7, 2018 Issued
Array ( [id] => 18349451 [patent_doc_number] => 20230137562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => TAU AGGREGATION INHIBITORS [patent_app_type] => utility [patent_app_number] => 16/615026 [patent_app_country] => US [patent_app_date] => 2018-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44224 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615026 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/615026
TAU AGGREGATION INHIBITORS Jun 6, 2018 Abandoned
Array ( [id] => 15513287 [patent_doc_number] => 10563221 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-18 [patent_title] => Insecticidal proteins and methods for their use [patent_app_type] => utility [patent_app_number] => 16/001133 [patent_app_country] => US [patent_app_date] => 2018-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 107177 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16001133 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/001133
Insecticidal proteins and methods for their use Jun 5, 2018 Issued
Array ( [id] => 13622883 [patent_doc_number] => 20180362993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-20 [patent_title] => ELICITOR-DERIVED PEPTIDES AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 15/989647 [patent_app_country] => US [patent_app_date] => 2018-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23334 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -38 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15989647 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/989647
ELICITOR-DERIVED PEPTIDES AND USE THEREOF May 24, 2018 Abandoned
Array ( [id] => 15071407 [patent_doc_number] => 10465180 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-05 [patent_title] => Factor IX polypeptide mutant, its uses and method for its production [patent_app_type] => utility [patent_app_number] => 15/989665 [patent_app_country] => US [patent_app_date] => 2018-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11935 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15989665 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/989665
Factor IX polypeptide mutant, its uses and method for its production May 24, 2018 Issued
Array ( [id] => 15931035 [patent_doc_number] => 20200157151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-21 [patent_title] => PEPTIDE COMPOUNDS, CONJUGATE COMPOUNDS AND USES THEREOF FOR TREATING INFLAMMATORY DISEASES [patent_app_type] => utility [patent_app_number] => 16/616098 [patent_app_country] => US [patent_app_date] => 2018-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19938 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616098 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/616098
PEPTIDE COMPOUNDS, CONJUGATE COMPOUNDS AND USES THEREOF FOR TREATING INFLAMMATORY DISEASES May 23, 2018 Abandoned
Array ( [id] => 15420657 [patent_doc_number] => 10543231 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-28 [patent_title] => Methods and materials for treating cancer [patent_app_type] => utility [patent_app_number] => 15/981656 [patent_app_country] => US [patent_app_date] => 2018-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10104 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15981656 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/981656
Methods and materials for treating cancer May 15, 2018 Issued
Array ( [id] => 20385448 [patent_doc_number] => 12485158 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-02 [patent_title] => Norrin induced expression of genes and use thereof to treat disease [patent_app_type] => utility [patent_app_number] => 16/611063 [patent_app_country] => US [patent_app_date] => 2018-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 16 [patent_no_of_words] => 4702 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16611063 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/611063
Norrin induced expression of genes and use thereof to treat disease May 6, 2018 Issued
Array ( [id] => 15931105 [patent_doc_number] => 20200157186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-21 [patent_title] => TRUNCATED VWF [patent_app_type] => utility [patent_app_number] => 16/610701 [patent_app_country] => US [patent_app_date] => 2018-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7178 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610701 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/610701
Truncated VWF May 3, 2018 Issued
Array ( [id] => 16452564 [patent_doc_number] => 20200361990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-19 [patent_title] => POLYPEPTIDE HAVING ANALGESIC ACTIVITY AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/762948 [patent_app_country] => US [patent_app_date] => 2018-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8533 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16762948 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/762948
Polypeptide having analgesic activity and use thereof May 1, 2018 Issued
Array ( [id] => 15960561 [patent_doc_number] => 20200164032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-28 [patent_title] => CHEMOKINE DECOY RECEPTORS OF RODENT GAMMAHERPESVIRUSES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/608672 [patent_app_country] => US [patent_app_date] => 2018-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25460 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608672 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/608672
Chemokine decoy receptors of rodent gammaherpesviruses and uses thereof Apr 26, 2018 Issued
Array ( [id] => 18341270 [patent_doc_number] => 11638739 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-02 [patent_title] => Inhibition of TREM receptor signaling with peptide variants [patent_app_type] => utility [patent_app_number] => 15/962589 [patent_app_country] => US [patent_app_date] => 2018-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 23783 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 263 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15962589 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/962589
Inhibition of TREM receptor signaling with peptide variants Apr 24, 2018 Issued
Menu